An Approach to Interpreting Spirometry

American Family Physician

Volumn 69, Issue 5, 2004, Pages 1107-1114

  Barreiro, Timothy J ^a,b   Perillo, Irene ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b STRONG MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CARBON MONOXIDE;

AIRWAY OBSTRUCTION; BREATHING PATTERN; COOPERATION; EQUIPMENT; HUMAN; LABORATORY; LUNG CAPACITY; LUNG DISEASE; LUNG FUNCTION; LUNG VOLUME; MEDICAL ASSESSMENT; MEDICAL TECHNOLOGY; QUALITY CONTROL; REVIEW; SPIROMETRY; STANDARD;

FAMILY PRACTICE; HUMANS; OFFICE VISITS; PULMONARY VENTILATION; RESPIRATORY TRACT DISEASES; SPIROMETRY; TERMINOLOGY;

EID: 1542377689     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Murray CJ, Lopez AD. Evidence-based health policy-lessons from the Global Burden of Disease Study. Science 1996;274:740-3.
2. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349: 1498-504.
3. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997;349:1436-42.
4. Holleman DR Jr, Simel DL. Does the clinical examination predict airflow limitation? JAMA 1995;273: 313-9.
5. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000;160:1683-9.
6. Kannel WB, Hubert H, Lew EA. Vital capacity as a predictor of cardiovascular disease: the Framingham study. Am Heart J 1983;105:311-5.
7. 1. The Lung Health Study. JAMA 1994;272:1497-505.
8. Harris T, Woteki C, Briefel RR, Kleinman JC. NHANES III for older persons: nutrition content and methodological considerations. Am J Clin Nutr 1989;50(5 Suppl):1145-9, 1231-5.
9. Petty TL, Weinmann GG. Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease. National Heart, Lung, and Blood Institute Workshop Summary. Bethesda, Maryland, August 29-31, 1995. JAMA 1997;277:246-53.
10. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-76.
11. Gold WM. Pulmonary function testing. In: Murray JF, Nadel JA, eds. Textbook of respiratory medicine, 3d ed. Philadelphia: Saunders, 2000:781-871.
12. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159:179-87.
13. Ferguson GT, Enright PL, Buist AS, Higgins MW. Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program. Chest 2000;117: 1146-61.
14. Salzman SH. Pulmonary function testing: tips on how to interpret the results. J Respir Dis 1999;20:809-22.
15. Alhamad EH, Lynch JP 3d, Martinez FJ. Pulmonary function tests in interstitial lung disease: what role do they have? Clin Chest Med 2001;22:715-50,ix.
16. Flaherty KR, Martinez FJ. The role of pulmonary function testing in pulmonary fibrosis. Curr Opin Pulm Med 2000;6:404-10.
17. Colp CR. Interpretation of pulmonary function tests. Chest 1979;76:377-8.
18. Rosenberg DM, Weinberger SE, Fulmer JD, Flye MW, Fauci AS, Crystal RG. Functional correlates of lung involvement in Wegener's granulomatosis. Use of pulmonary function tests in staging and follow-up. Am J Med 1980;69:387-94.
19. Kanji Z, Sunderji R, Gin K. Amiodarone-induced pulmonary toxicity. Pharmacotherapy 1999;19:1463-6.
20. Dunn WF, Scanlon PD. Preoperative pulmonary function testing for patients with lung cancer. Mayo Clin Proc 1993;68:371-7.
21. Celli BR. What is the value of preoperative pulmonary function testing? Med Clin North Am 1993;77:309-25.
22. Culver BH. Preoperative assessment of the thoracic surgery patient: pulmonary function testing. Semin Thorac Cardiovasc Surg 2001;13:92-104.
23. Powell CA, Caplan CE. Pulmonary function tests in preoperative pulmonary evaluation. Clin Chest Med 2001;22:703-14, viii.
24. Sood A, Redlich CA. Pulmonary function tests at work. Clin Chest Med 2001;22:783-93.
25. Crapo RO. Pulmonary-function testing. N Engl J Med 1994;331:25-30.
26. Crapo RO, Morris AH. Pulmonary function testing: sources of error in measurement and interpretation. South Med J 1989;82:875-9.
27. Petty TL. Simple office spirometry. Clin Chest Med 2001;22:845-59.
28. Margolis ML, Montoya FJ, Palma WR Jr. Pulmonary function tests: comparison of 95th percentile-based and conventional criteria of normality. South Med J 1997;90:1187-91.
29. Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am J Respir Crit Care Med 1991;144:1202-18.